权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Reactive astrocytes from gliotic capsule

来自胶质细胞囊的反应性星形胶质细胞

基本信息

批准号：
7248697
负责人：
J. Marc Simard
金额：
$ 26.05万
依托单位：
UNIVERSITY OF MARYLAND BALTIMORE
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
起止时间：
2004-09-15 至 2008-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7248697
关键词：
Affect Animals Antisense Oligonucleotides Astrocytes Biological Brain Brain Edema Cations Cell Death Cell Survival Cells Cellular biology Cerebral Edema Cessation of life Condition Data Development Diazoxide Edema Estradiol Estrogens Female Foreign Bodies GTP-Binding Proteins Glyburide Goals Human Hypoxia Immune system Implant In Vitro Infusion procedures Injury Label Medical Surveillance Microglia Necrosis Numbers Patients Phosphatidylinositol 4,5-Diphosphate Proteins Pump Rattus Regulation Role Shelter facility Signal Pathway Site Sulfonylurea Compounds System Techniques Tight Junctions Tissues capsule cell type chemokine cytokine day gliotic capsule hypoxia inducible factor 1 improved in vivo inhibitor/antagonist killings male neglect neutrophil non-genomic novel patch clamp protein expression research study response response to injury

项目摘要

DESCRIPTION (provided by applicant): The gliotic capsule that forms around a "foreign body" in the brain is an important, albeit neglected, biological system. Although beneficial overall, the gliotic capsule forms a potentially harmful mass of tissue that contributes to brain swelling and mass effect, and that may shelter foreign cells from surveillance by the immune system. We have found that, in a variety pathological conditions in both rats and humans, reactive astrocytes (R1 astrocytes) in the inner zone of the gliotic capsule express a novel SURl-regulated cation channel, the NCca-ATPchannel, and that this channel directly controls cell viability: opening the channel is associated with necrotic cell death and closing the channel is associated with protection from cell death induced by energy depletion. This discovery can be exploited to allow pharmacological manipulation of R1 astrocytes, leading not only to improved understanding of the basic cellular biology of the gliotic capsule, but also to techniques that will allow manipulation of capsule formation to improve treatment of patients. In Aim 1 of this proposal, we will expand on preliminary data showing that inhibiting the NCca-ATPchannel protects R1 astrocytes from cell death. We will look at 2 ways to inhibit the channel, with the sulfonylurea, glybenclamide, and with estrogen. In the first part of Aim 1, we will examine in detail the mechanism by which estrogen blocks channel activity, building on preliminary data in which we found that activity of the NCca-ATPchannel in both males and females is inhibited by estrogen via a non-genomic signaling pathway. In the second part of Aim 1, we will use estrogen and glybenclamide to examine the effect of channel inhibition on formation of the gliotic capsule and on development of cerebral edema in vivo. In Aim 2, we will expand on preliminary data showing that selective killing of R1 astrocytes by diazoxide infusion, which in vitro causes channel opening and necrotic death of R1 astrocytes, results in expansion of the overall astrogliotic response and recruitment of enormous numbers of neutrophils. We will study this response in detail and assess the role of microglia and cytokines in this altered response to injury. In Aim 3, we will expand on preliminary data showing that expression of the NCca-ATPchannel in vitro requires conditions of hypoxia, and that the inner zone of the gliotic capsule where the channel is found in vivo is hypoxic, suggesting a critical role for hypoxia/HIF1 in channel expression. We will study the role of HIF-1 by inhibiting its expression using antisense oligodeoxynucleotide infusion. Overall, we expect that these studies will build on our recent discovery of the novel SURl-regulated NCca-ATPchannel, and will help to elucidate the function of R1 astrocytes in the inner zone of the gliotic capsule.

描述（由申请人提供）：在大脑中的“异物”周围形成的神经胶质囊是一个重要的生物系统，尽管被忽视。虽然总体上是有益的，但神经胶质囊形成了一个潜在有害的组织块，导致脑肿胀和质量效应，并可能保护外来细胞免受免疫系统的监视。我们已经发现，在大鼠和人类的各种病理条件下，神经胶质囊内区的反应性星形胶质细胞（R1星形胶质细胞）表达一种新的SUR 1调节的阳离子通道，NCca-ATP通道，并且该通道直接控制细胞活力：打开通道与坏死细胞死亡相关，关闭通道与保护免于能量耗尽诱导的细胞死亡相关。这一发现可以被利用来允许R1星形胶质细胞的药理学操作，不仅导致对胶质细胞囊的基本细胞生物学的更好的理解，而且还导致允许操纵囊形成以改善患者治疗的技术。在本提案的目标1中，我们将扩展初步数据，表明抑制NCca-ATP通道可保护R1星形胶质细胞免于细胞死亡。我们将研究两种抑制该通道的方法，磺脲类药物、格列本脲和雌激素。在目标1的第一部分，我们将详细研究雌激素阻断通道活性的机制，建立在初步数据的基础上，我们发现，在男性和女性的NCca-ATP通道的活性通过非基因组信号通路被雌激素抑制。在目标1的第二部分中，我们将使用雌激素和格列本脲来检查通道抑制对胶质细胞囊形成和体内脑水肿发展的影响。在目标2中，我们将扩大初步数据显示，二氮嗪输注，在体外导致通道开放和R1星形胶质细胞坏死死亡的R1星形胶质细胞的选择性杀伤，结果在扩大的整体星形胶质细胞反应和招聘的大量中性粒细胞。我们将详细研究这种反应，并评估小胶质细胞和细胞因子在这种改变的损伤反应中的作用。在目标3中，我们将扩大初步数据显示，NCca-ATP通道在体外的表达需要缺氧的条件下，和神经胶质细胞囊的内部区域，在那里发现的通道在体内是缺氧的，这表明缺氧/HIF 1在通道表达的关键作用。我们将研究HIF-1的作用，通过使用反义寡核苷酸输注抑制其表达。总的来说，我们希望这些研究将建立在我们最近发现的新的SUR 1调节的NCca-ATP通道，并将有助于阐明R1星形胶质细胞在胶质细胞囊内区的功能。